Evaluating kratom alkaloids using PHASE

Kratom is a botanical substance that is marketed and promoted in the US for pharmaceutical opioid indications despite having no US Food and Drug Administration approved uses. Kratom contains over forty alkaloids including two partial agonists at the mu opioid receptor, mitragynine and 7-hydroxymitra...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Christopher R., Racz, Rebecca, Kruhlak, Naomi L., Kim, Marlene T., Zakharov, Alexey V., Southall, Noel, Hawkins, Edward G., Burkhart, Keith, Strauss, David G., Stavitskaya, Lidiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053747/
https://www.ncbi.nlm.nih.gov/pubmed/32126112
http://dx.doi.org/10.1371/journal.pone.0229646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053747/
https://www.ncbi.nlm.nih.gov/pubmed/32126112
http://dx.doi.org/10.1371/journal.pone.0229646

Ejemplares similares